These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 16277026

  • 1. Effects of hormone replacement therapy on the main fatty acids of serum and phospholipids of postmenopausal women.
    Piperi C, Tzivras M, Kalofoutis C, Skenderi A, Michalaki V, Kalofoutis A.
    In Vivo; 2005; 19(6):1081-5. PubMed ID: 16277026
    [Abstract] [Full Text] [Related]

  • 2. Fatty acid composition of serum phospholipid of premenopausal women and postmenopausal women receiving and not receiving hormone replacement therapy.
    Stark KD, Park EJ, Holub BJ.
    Menopause; 2003; 10(5):448-55. PubMed ID: 14501607
    [Abstract] [Full Text] [Related]

  • 3. Evidence of improved serum fatty acid profile of postmenopausal women receiving atorvastatin and raloxifene.
    Piperi C, Zisaki K, Skenderi K, Kalofoutis C, Kalofoutis A.
    J Obstet Gynaecol; 2005 Jul; 25(5):476-81. PubMed ID: 16183584
    [Abstract] [Full Text] [Related]

  • 4. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P.
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [Abstract] [Full Text] [Related]

  • 5. Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy.
    Toth MJ, Sites CK, Matthews DE.
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E639-46. PubMed ID: 16684855
    [Abstract] [Full Text] [Related]

  • 6. The benefits of hormone replacement therapy on plasma and platelet antioxidant status and fatty acid composition in healthy postmenopausal women.
    Gokkusu C, Tata G, Ademoğlu E, Tamer S.
    Platelets; 2010 Sep; 21(6):439-44. PubMed ID: 20459351
    [Abstract] [Full Text] [Related]

  • 7. Age-related cognitive decline in the menopause: effects of hormone replacement therapy on cognitive event-related potentials.
    Anderer P, Saletu B, Gruber D, Linzmayer L, Semlitsch HV, Saletu-Zyhlarz G, Brandstätter N, Metka M, Huber J.
    Maturitas; 2005 Jul 16; 51(3):254-69. PubMed ID: 15978969
    [Abstract] [Full Text] [Related]

  • 8. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J, Klein K, Brosnihan B, Reboussin D, Herrington DM.
    Menopause; 2008 Jul 16; 15(6):1060-4. PubMed ID: 18521047
    [Abstract] [Full Text] [Related]

  • 9. Sequentially combined estradiol valerate plus levonorgestrel therapy decreases 18:1 trans-fatty acid content of plasma lipids in healthy postmenopausal women.
    Jokela H, Kalela A, Lilja M, Salmi M, Lehtimäki T, Kunnas T, Teisala K, Punnonen R, Nikkari ST.
    Gynecol Endocrinol; 2005 Dec 16; 21(6):360-5. PubMed ID: 16390785
    [Abstract] [Full Text] [Related]

  • 10. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
    Sumino H, Ichikawa S, Takahashi T, Sakamoto H, Goto-Onozato K, Koya S, Kanda T, Nara M, Seki K, Murakami M, Kurabayashi M.
    Maturitas; 2006 Feb 20; 53(3):306-14. PubMed ID: 16040211
    [Abstract] [Full Text] [Related]

  • 11. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV, Khalil RA.
    Expert Rev Cardiovasc Ther; 2007 Jul 20; 5(4):777-89. PubMed ID: 17605655
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
    Kwok S, Selby PL, McElduff P, Laing I, Mackness B, Mackness MI, Prais H, Morgan J, Yates AP, Durrington PN, Sci FM.
    Clin Endocrinol (Oxf); 2004 Dec 20; 61(6):760-7. PubMed ID: 15579192
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S, Mercuri A, Prontera C, Zucchelli GC, Vassalle C.
    Climacteric; 2006 Dec 20; 9(6):452-8. PubMed ID: 17085378
    [Abstract] [Full Text] [Related]

  • 16. The benefits of androgens combined with hormone replacement therapy regarding to patients with postmenopausal sexual symptoms.
    de Paula FJ, Soares JM, Haidar MA, de Lima GR, Baracat EC.
    Maturitas; 2007 Jan 20; 56(1):69-77. PubMed ID: 16822626
    [Abstract] [Full Text] [Related]

  • 17. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 20; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 18. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P, Tankó LB, Bagger YZ, Qin G, Christiansen C.
    Climacteric; 2006 Apr 20; 9(2):108-18. PubMed ID: 16698657
    [Abstract] [Full Text] [Related]

  • 19. Effect of vitamin E supplementation with and without hormone therapy on circulatory inflammatory markers in postmenopausal women.
    Carr BR, Khan N, Adams-Huet B, Kakarla N, Havelock JC, Gell J.
    Fertil Steril; 2006 Mar 20; 85(3):667-73. PubMed ID: 16500336
    [Abstract] [Full Text] [Related]

  • 20. [On the modification of serum lipids in healthy postmenopausal women by conjugated estrogens. II].
    Florian HJ, Burger H, Holzmann G.
    Z Geburtshilfe Gynakol; 1969 Apr 20; 170(2):118-24. PubMed ID: 4306594
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.